Vascular Biogenics Ltd. VBLT

$ 0.16 -8.77%

Quarterly report 2024-Q2
added 08-14-2024

Vascular Biogenics Ltd. Income Statement 2011-2024 | VBLT

Annual Income Statement Vascular Biogenics Ltd.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	528 K	98.3 K	131 M	109 M	54.9 M	42.5 M	197 M	127 M	61.3 M	19.4 T	-	-	-
Shares	3.3 M	656 K	66.3 M	43.7 M	35.9 M	33 M	27.4 M	25 M	19.9 M	1.23 T	-	-	-
Historical Prices	0.16	0.15	1.97	1.89	1.2	0.97	7.1	4.85	5.26	5.91	-	-	-
Net Income	-11.3 M	-14.4 M	-29.9 M	-24.2 M	-19.5 M	-20.5 M	-10.1 M	-	-	-	-16 M	-12.2 M	-
Revenue	310 K	8 K	768 K	922 K	562 K	585 K	13.9 M	-	-	-	-	-	-
Cost of Revenue	197 K	104 K	365 K	394 K	222 K	255 K	-	-	-	-	-	-	-
Gross Profit	113 K	8 K	403 K	528 K	399 K	350 K	13.5 M	-	-	-	-	-	-
Operating Income	-14.7 M	-12.9 M	-30 M	-24.5 M	-20.1 M	21.2 M	-	-	-	-	-	-	-
Interest Expense	179 K	1.03 M	44 K	105 K	184 K	159 K	-	-	-	-	-	-	-
EBITDA	-14.4 M	-12.6 M	-28.7 M	-23.3 M	-18.3 M	-20.1 M	-10.5 M	130 K	122 K	135 K	-16.1 M	-12.3 M	-
Operating Expenses	14.8 M	12.9 M	-	25 M	20.4 M	21.6 M	24.2 M	16.3 M	14.9 M	14.8 M	16 M	-	-
General and Administrative Expenses	10.1 M	5.16 M	7.7 M	5.36 M	5.22 M	5.71 M	5.8 M	3.83 M	-131 K	1.35 M	3.79 M	1.88 M	-

All numbers in USD currency

Quarterly Income Statement Vascular Biogenics Ltd.

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	9.46 M	9.02 M	9.02 M	2.24 M	970 K	970 K	1.99 M	2.22 M	77.4 M	77.4 M	68.7 M	70.3 M	68.1 M	52.1 M	48.2 M	47.9 M	42.7 M	36.1 M	35.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-5.22 M	-3.77 M	-	-1.07 M	-3.44 M	-6.27 M	-	-9.17 M	-9.43 M	-10.4 M	-	-6.5 M	-8.03 M	-6.28 M	-	-5.78 M	-5.83 M	5.35 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	2 K	1 K	-	-	-	-	-	481 K	64 K	113 K	-	199 K	188 K	185 K	-	193 K	158 K	366 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	2 K	-	63 K	34 K	55 K	-	91 K	89 K	90 K	-	132 K	21 K	145 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	2 K	1 K	-	-	-	-2 K	-	418 K	30 K	58 K	-	108 K	99 K	95 K	-	61 K	137 K	221 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-5.38 M	-3.84 M	-	-1 M	-2.99 M	-5.52 M	-	-9.28 M	-9.61 M	-10.6 M	-	-6.51 M	-8.02 M	-6.35 M	-	-5.82 M	-5.86 M	5.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	61 K	61 K	-	63 K	1 K	16 K	-	35 K	25 K	10 K	-	8 K	7 K	20 K	-	13 K	11 K	15 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-3.78 M	-	-	-	-5.45 M	-	-9.28 M	-9.61 M	-10.2 M	-	-6.51 M	-8.02 M	-6.05 M	-	-5.82 M	-5.86 M	5.93 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	5.38 M	3.84 M	-	-	2.99 M	5.52 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.03 M	2.29 M	-	1.85 M	1.93 M	3.92 M	-	3.75 M	2.92 M	3.16 M	-	1.62 M	1.48 M	1.67 M	-	1.28 M	1.34 M	1.34 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency